Company Monitoring Page for Amgen

latest headlines for company on cafepharma

Biopharma’s 5 Biggest M&A Deals of 2022
BioSpace
Wed, 12/14/22 - 10:50 am
Tags:
M&A, Amgen, Horizon Therapeutics, Pfizer, Biohaven, Global Blood Therapeutics, Bristol Myers Squibb, Turning Point Therapeutics, ChemoCentryx
FDA Approval of Mirati Lung Cancer Drug Sets Stage for Competition With Amgen
MedCity News
Wed, 12/14/22 - 10:19 am
Tags:
Amgen, Mirati Therapeutics, Krazati, Lumakras, FDA, lung cancer
Amgen to Buy Horizon in Biotech’s Biggest Deal of 2022
BioSpace
Mon, 12/12/22 - 10:34 am
Tags:
Amgen, Horizon Therapeutics, M&A
Could Amgen's Heart Disease Candidate Generate Billions in Sales?
Motley Fool
Sun, 12/11/22 - 01:26 pm
Tags:
Amgen, heart disease, olpasiran
Senate Finance chair goes after Amgen again on US taxes, asking for payment specifics
Endpoints
Thu, 12/8/22 - 11:25 pm
Tags:
Senate, taxes, Amgen
Amgen to push latecomer obesity drug into midstage testing
Pharmaphorum
Sun, 12/4/22 - 01:26 pm
Tags:
Amgen, Novo Nordisk, Eli Lilly, obesity, clinical trials, AMG 133
With buyout on Horizon, Amgen and Sanofi eye cash plays for rare disease drug maker
Fierce Pharma
Fri, 12/2/22 - 11:13 am
Tags:
Horizon Therapeutics, Sanofi, Amgen, M&A
J&J sues Amgen over plan to sell drug similar to Stelara
Business Insurance
Thu, 12/1/22 - 10:48 am
Tags:
JNJ, Janssen, Amgen, legal, ulcerative colitis, patents, Stelara
Large pharmas probe takeover of Horizon Therapeutics
BioPharma Dive
Wed, 11/30/22 - 10:58 am
Tags:
Horizon Pharma, M&A, JNJ, Sanofi, Amgen
Mirati is once again the subject of Big Pharma takeover talks: report
Fierce Biotech
Sun, 11/27/22 - 07:08 pm
Tags:
Mirati Therapeutics, M&A, Amgen, Lumakras
Best Places to Work in Biopharma 2023 Report Reveals Most Sought-After Employers
BioSpace
Mon, 11/14/22 - 10:59 am
Tags:
biotech, biopharma, employers, corporate culture, Moderna Therapeutics, Genentech, Pfizer, Amgen, AbbVie
Arrowhead Gets $250M in Royalty Deal for Cardio Drug Heading to Phase 3
MedCity News
Wed, 11/9/22 - 11:30 pm
Tags:
Amgen, Arrowhead Pharmaceuticals, olpasiran, heart disease
Early data hint at benefit for Amgen’s obesity drug
BioPharma Dive
Wed, 11/9/22 - 10:32 am
Tags:
Amgen, obesity, Eli Lilly, Novo Nordisk, AMG 133
Amgen to test new way to lower heart risk with large drug trial
BioPharma Dive
Mon, 11/7/22 - 11:00 am
Tags:
Amgen, clinical trials, heart disease, olpasiran
Amgen's Supreme Court bid answered in long-running Repatha patent feud against Sanofi, Regeneron
Fierce Pharma
Mon, 11/7/22 - 10:55 am
Tags:
Amgen, Repatha, patents, Supreme Court, Sanofi, Regeneron
What Pharma Companies Can Expect From the Influx of Humira Biosimilars
Drug Channels
Fri, 10/14/22 - 10:15 am
Tags:
AbbVie, Humira, biosimilars, Amgen, Amjevita
Amgen study: Biosimilars saved the healthcare system $21B
Medical Marketing and Media
Wed, 10/12/22 - 11:38 pm
Tags:
Amgen, biosimilars
Why Amgen Is Up More Than 6% Today
Motley Fool
Tue, 10/11/22 - 04:05 pm
Tags:
Amgen, AMG133, obesity
R&D acceleration: Amgen opens its second largest research site, with lab and office space for 650 staff
Endpoints
Fri, 10/7/22 - 11:02 am
Tags:
Amgen, R&D
SITC 2022 preview – cytokines and oral checkpoints
EP Vantage
Thu, 10/6/22 - 10:39 am
Tags:
SITC, Incyte, ChemoCentryx, Amgen, cytokines

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.